Airway disease, hypertension, endocarditis, CAD/dyslipidemia, heart failure, antiarrhythmics, anemias, DVT/thromboembolism
SABA PRN
SABA PRN and low dose ICS
SABA PRN, low dose ICS and LABA
SABA PRN, medium dose ICS and LABA
SABA PRN, high dose ICS and LABA, consider omalizumab
Intermittent
Mild persistent
Moderate persistent
Severe persistent
Symptoms occur less than 2 days per week
FEV1 is greater than 80% predicted or at personal best
There is no interference with normal activities
Nighttime awakenings occur less than twice per week
Theophylline
Levalbuterol
Albuterol
Salmeterol
Beta-2 agonists
Methylxanthines
Anticholinergics
Corticosteroids
Smoking
Phenytoin
Oral contraceptives
Erythromycin
1-10 mg/dL
5-15 mg/dL
1-15 mg/dL
5-20 mg/dL
CNS stimulation
Arrhythmia
Dysphonia
Convulsions
Beta-2 Agonists
Anticholinergics
Corticosteroids
Leukotriene modifiers
Pts should put the inhaler in their mouth, especially when using steroids.
The patient should wait 15-30 seconds between puffs in all inhalers except SABAs
The patient should press the inhaler while breathing out slowly and deeply
Patients should hold their breath as they count to ten slowly if possible.
Asthma
COPD
Hypertension
Endocarditis
Hydrochlorothiazide
Spironolactone
Furosemide
Amiloride
Atenolol
Propanolol
Metoprolol
Acebutolol